基团效率：从活性分子到先导化合物的化学研究指南。 - Suppr

Group efficiency: a guideline for hits-to-leads chemistry.

作者信息

Verdonk Marcel L, Rees David C

机构信息

Astex Therapeutics Ltd., 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, UK.

出版信息

ChemMedChem. 2008 Aug;3(8):1179-80. doi: 10.1002/cmdc.200800132.

DOI:10.1002/cmdc.200800132

PMID:18651625

Abstract

摘要

相似文献

Group efficiency: a guideline for hits-to-leads chemistry.

ChemMedChem. 2008 Aug;3(8):1179-80. doi: 10.1002/cmdc.200800132.

Introduction: Human metabolites in safety testing (MIST) issue.

Chem Res Toxicol. 2009 Feb;22(2):237-8. doi: 10.1021/tx900003k.

Substrate Activity Screening (SAS) and Related Approaches in Medicinal Chemistry.

ChemMedChem. 2016 Mar 4;11(5):467-76. doi: 10.1002/cmdc.201500569. Epub 2016 Feb 4.

University investment in drug discovery.

Science. 2005 Nov 4;310(5749):777. doi: 10.1126/science.310.5749.777b.

Medicinal chemistry: defining itself.

ChemMedChem. 2008 Aug;3(8):1147-9. doi: 10.1002/cmdc.200800116.

[Strategy of molecular drug design: hits, leads and drug candidates].

Yao Xue Xue Bao. 2008 Sep;43(9):898-904.

Editorial. Reviews by editorial board.

Anticancer Agents Med Chem. 2008 Aug;8(6):576.

Molecular biology. Universities join the screening bandwagon.

Science. 2008 Aug 8;321(5890):766. doi: 10.1126/science.321.5890.766.

The scope and requirements related to preclinical and clinical studies of a new medicinal product, including biotechnological and biosimilar products.

Acta Pol Pharm. 2008 Nov-Dec;65(6):641-5.

Molecular biology. Industrial-style screening meets academic biology.

Science. 2008 Aug 8;321(5890):764-6. doi: 10.1126/science.321.5890.764.

引用本文的文献

A Perspective on the Strategic Application of Deconstruction-Reconstruction in Drug Discovery.

J Med Chem. 2025 Jun 12;68(11):10520-10539. doi: 10.1021/acs.jmedchem.5c00036. Epub 2025 May 5.

Forces Driving a Magic Bullet to Its Target: Revisiting the Role of Thermodynamics in Drug Design, Development, and Optimization.

Life (Basel). 2022 Sep 15;12(9):1438. doi: 10.3390/life12091438.

In Silico Structure-Based Approach for Group Efficiency Estimation in Fragment-Based Drug Design Using Evaluation of Fragment Contributions.

Molecules. 2022 Mar 18;27(6):1985. doi: 10.3390/molecules27061985.

Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads.

Cells. 2021 Dec 6;10(12):3431. doi: 10.3390/cells10123431.

Unique Diacidic Fragments Inhibit the OXA-48 Carbapenemase and Enhance the Killing of Producing OXA-48.

ACS Infect Dis. 2021 Dec 10;7(12):3345-3354. doi: 10.1021/acsinfecdis.1c00501. Epub 2021 Nov 24.

Pushing the Ligand Efficiency Metrics: Relative Group Contribution (RGC) Model as a Helpful Strategy to Promote a Fragment "Rescue" Effect.

Front Chem. 2019 Aug 16;7:564. doi: 10.3389/fchem.2019.00564. eCollection 2019.

The nature of ligand efficiency.

J Cheminform. 2019 Jan 31;11(1):8. doi: 10.1186/s13321-019-0330-2.

Synthesis, In Silico, and In Vitro Evaluation of Long Chain Alkyl Amides from 2-Amino-4-Quinolone Derivatives as Biofilm Inhibitors.

Molecules. 2019 Jan 17;24(2):327. doi: 10.3390/molecules24020327.

Pharmacological Characterization of 5-Substituted 1-[(2,3-dihydro-1-benzofuran-2-yl)methyl]piperazines: Novel Antagonists for the Histamine H and H Receptors with Anti-inflammatory Potential.

Front Pharmacol. 2017 Nov 14;8:825. doi: 10.3389/fphar.2017.00825. eCollection 2017.

Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure.

ACS Med Chem Lett. 2017 Feb 8;8(3):316-320. doi: 10.1021/acsmedchemlett.6b00481. eCollection 2017 Mar 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Group efficiency: a guideline for hits-to-leads chemistry.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Group efficiency: a guideline for hits-to-leads chemistry.

作者信息

机构信息

出版信息

相似文献

引用本文的文献